Intus Healthcare and Fisher & Paykel Healthcare have announced that they will be actively working together to reduce the number of undiagnosed OSA sufferers and additionally join forces to strengthen their individual NHS tender submissions.
In the UK, an estimated two million people have undiagnosed OSA and a recent research report published by the Sleep Apnoea Trust Association (SATA) found that while (approx.) 100,000 sleep studies are conducted via the NHS each year, the system is always under great pressure, resulting in a considerable number of untreated patients. Among other activities, a joint Intus/F&P advertising campaign, which launched in The Times newspaper in April, will seek to raise OSA symptom awareness to a targeted public and encourage enquirers to undertake an in-home sleepy study (www.Sleep-Study.co.uk/FPH) to investigate further. F&P provide an excellent range of OSA therapy equipment and Intus have been running an efficient in-home sleep study service for many years, with studies analysed by clinically trained professionals turning around results in just seven days.
With the increasing requirement for the NHS to outsource services to help relieve backlogs and cut costs, many NHS tenders stipulate the need for suppliers to provide a 'complete' patient care pathway - from diagnosis to therapy provision with follow-ups and aftercare. Intus have the infrastructure and experience to provide these services, having directly served tens of thousands of patients. Now, by combining F&P and Intus' strength's both company's tender proposals will be of greater interest and ultimately help more people to get the sleep they deserve.
In the UK, an estimated two million people have undiagnosed OSA and a recent research report published by the Sleep Apnoea Trust Association (SATA) found that while (approx.) 100,000 sleep studies are conducted via the NHS each year, the system is always under great pressure, resulting in a considerable number of untreated patients. Among other activities, a joint Intus/F&P advertising campaign, which launched in The Times newspaper in April, will seek to raise OSA symptom awareness to a targeted public and encourage enquirers to undertake an in-home sleepy study (www.Sleep-Study.co.uk/FPH) to investigate further. F&P provide an excellent range of OSA therapy equipment and Intus have been running an efficient in-home sleep study service for many years, with studies analysed by clinically trained professionals turning around results in just seven days.
With the increasing requirement for the NHS to outsource services to help relieve backlogs and cut costs, many NHS tenders stipulate the need for suppliers to provide a 'complete' patient care pathway - from diagnosis to therapy provision with follow-ups and aftercare. Intus have the infrastructure and experience to provide these services, having directly served tens of thousands of patients. Now, by combining F&P and Intus' strength's both company's tender proposals will be of greater interest and ultimately help more people to get the sleep they deserve.
RSS Feed